Asston Pharmaceuticals Ltd — Important, 10-07-2026: Company Update

Asston Pharmaceuticals Limited has announced its second Extraordinary General Meeting for the financial year 2026-27. The meeting will be conducted through Video Conferencing or Other Audio Visual Means to address specific business outlined in the EGM Notice. Shareholders can exercise their voting rights either via remote e-voting during a designated window or through e-voting available during the meeting. This EGM provides an important platform for investors to participate in key company decisions.